Stock VYNE VYNE THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector consensus VYNE Therapeutics Inc.

Equities

VYNE

US92941V3087

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 04:00:00 2025-01-22 pm EST 		5-day change 1st Jan Change
2.720 USD -1.81% Intraday chart for VYNE Therapeutics Inc. -1.09% -18.81%
Jan. 06 VYNE Therapeutics Completes Enrollment in Phase 2B Trial Evaluating Vyn201 for the Treatment of Nonsegmental Vitiligo CI
Dec. 23 VYNE Therapeutics Reports 'Positive' Phase 1a Results for VYN202 Inhibitor MT
Main competitors
Add to a list
Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 Analyst Opinion 4m Target Price Revision 4m Revision of opinion Divergence of analysts' opinions Divergence of Target Price Average Target P. Ecart obj. / dr Nbr of analysts
VYNE THERAPEUTICS INC. Stock VYNE Therapeutics Inc.
 6.188 +123.38%4
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 489.81 +14.47%30
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 1,005.61 +46.21%25
ARGENX SE Stock argenx SE
 624.47 -0.31%16
BIONTECH SE Stock BioNTech SE
 133.80 +18.72%20
BEIGENE, LTD. Stock BeiGene, Ltd.
 283.39 +29.58%23
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
 64.30 +15.88%17
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
 167.67 +14.94%24
SUMMIT THERAPEUTICS INC. Stock Summit Therapeutics Inc.
 26.81 +49.45%7
GENMAB A/S Stock Genmab A/S
 2,314.56 +50.74%16
INSMED INCORPORATED Stock Insmed Incorporated
 88.14 +14.84%16
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
 184.91 +58.33%21
VAXCYTE, INC. Stock Vaxcyte, Inc.
 149.89 +70.00%9
EXELIXIS, INC. Stock Exelixis, Inc.
 35.61 -2.26%22
WUXI BIOLOGICS (CAYMAN) INC. Stock WuXi Biologics (Cayman) Inc.
 19.25 +13.25%25
ASCENDIS PHARMA A/S Stock Ascendis Pharma A/S
 187.08 +46.90%15
PHARMAESSENTIA CORPORATION Stock PharmaEssentia Corporation
 854.80 +23.35%5
AKESO, INC. Stock Akeso, Inc.
 71.33 +29.47%18
ZEALAND PHARMA A/S Stock Zealand Pharma A/S
 1,007.64 +37.75%11
Average 406.07 +34.46% 17
Weighted average by Cap. 515.83 +25.85% 22
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. VYNE Stock
  4. Sector VYNE Therapeutics Inc.
  5. Sector consensus